Introduction COVID-19 has a wide range of clinical manifestations. Neurological
manifestations in COVID-19 patients were demonstrated during the pandemic, including …

Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-
2 infection and is associated with both acute and chronic disorders affecting the nervous …

Objective We sought to review the literature on cerebrospinal fluid (CSF) testing in patients
with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods We performed …

Purpose Little is known about the neuronal substrates of neuropsychiatric symptoms
associated with COVID-19 and their evolution during the course of the disease. We aimed at …

Neurological symptoms in patients with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection are commen [1]. SARS-CoV-2-RNA was detected by reverse …

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) predominantly
infects the respiratory system, several investigations have shown the involvement of the …

Objective To systematically describe central (CNS) and peripheral (PNS) nervous system
complications in hospitalized COVID-19 patients. Methods We conducted a prospective …

Objective Many neurological manifestations are associated with COVID‐19, including a
distinct form of encephalopathy related to cytokine storm, the acute systemic inflammatory …

Cognitive impairment following SARS-CoV-2 infection is being increasingly recognized as
an acute and possibly also long-term sequela of the disease. Direct viral entry as well as …

Acute delirium and other neuropsychiatric symptoms have frequently been reported in
COVID-19 patients and are variably referred to as acute encephalopathy, COVID-19 …